Clinical Trials Logo

Psychotic Symptoms clinical trials

View clinical trials related to Psychotic Symptoms.

Filter by:
  • None
  • Page 1

NCT ID: NCT04038788 Completed - Schizophrenia Clinical Trials

Add-on HD Hf-tRNS Over Bilateral DLPFC for Treating Patients With Schizophrenia

Start date: October 24, 2018
Phase: N/A
Study type: Interventional

The study aimed to investigate the effects of high-definition transcranial random noise stimulation over bilateral prefrontal cortex on psychopathological symptoms, other clinical outcomes, autonomic functioning ,and brain oscillatory activity in schizophrenia patients.

NCT ID: NCT03701100 Completed - Schizophrenia Clinical Trials

The Effects of Bimodal tDCS on Illness Severity, Insight, Functional Outcomes, Neurocognition and HRV in Schizophrenia

Start date: July 17, 2017
Phase: N/A
Study type: Interventional

The study aimed to investigate the effects of bimodal anodal transcranial direct current stimulation (tDCS) over bilateral dorsolateral prefrontal cortex (DLPFC) on psychopathological symptoms, insight, psychosocial functioning, neurocognitive function and heart rate variability (HRV) in schizophrenia patients

NCT ID: NCT02615652 Completed - Psychotic Symptoms Clinical Trials

The Impact of Lifestyle on Mental Health Among Young Men in the Gilgel Gibe Field Research Center, Ethiopia: Pilot Study

Start date: December 2015
Phase: N/A
Study type: Observational

Researchers of the three collaborating universities implement a pilot observational study in "Gilgel Gibe Field Research Center", a health and demographic surveillance system run by the Jimma University, Ethiopia. In this setting, the investigators plan to study risk factors in young men for the development of common mental disorders and psychotic symptoms and the stability of distinct symptoms of mental disorders in the community. The investigators will explore in particular the impact of lifestyle on mental health in young men, including the traditional habit of chewing khat leaves, which contain amphetamine-like cathinone. Furthermore, the investigators want to demonstrate the reliability and validity of assessments performed by trained local interviewers.